BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9500869)

  • 1. Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy.
    Williams SA; Tappia PS; Yu CH; Bibeau M; Panagia V
    J Mol Cell Cardiol; 1998 Jan; 30(1):109-18. PubMed ID: 9500869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular alterations in cardiac phospholipase D activity in chronic diabetes.
    Williams SA; Tappia PS; Yu CH; Binaglia L; Panagia V; Dhalla NS
    Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):95-9. PubMed ID: 9250614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential changes in phospholipase D and phosphatidate phosphohydrolase activities in ischemia-reperfusion of rat heart.
    Asemu G; Dent MR; Singal T; Dhalla NS; Tappia PS
    Arch Biochem Biophys; 2005 Apr; 436(1):136-44. PubMed ID: 15752718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidic acid and diacylglycerol generation is regulated by insulin in cerebral cortex synaptosomes from adult and aged rats.
    Salvador GA; Ilincheta de Boschero MG; Pasquaré SJ; Giusto NM
    J Neurosci Res; 2005 Jul; 81(2):244-52. PubMed ID: 15948152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure.
    Yu CH; Panagia V; Tappia PS; Liu SY; Takeda N; Dhalla NS
    Biochim Biophys Acta; 2002 Sep; 1584(1):65-72. PubMed ID: 12213494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus.
    Burgdorf C; Hänsel L; Heidbreder M; Jöhren O; Schütte F; Schunkert H; Kurz T
    Biochem Biophys Res Commun; 2009 Dec; 390(1):165-70. PubMed ID: 19799857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-stimulated cortisol secretion is mediated by phospholipase D.
    Rábano M; Peña A; Brizuela L; Macarulla JM; Gómez-Muñoz A; Trueba M
    Mol Cell Endocrinol; 2004 Jul; 222(1-2):9-20. PubMed ID: 15249121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway.
    Abdelghaffar H; Vazifeh D; Labro MT
    J Immunol; 1997 Oct; 159(8):3995-4005. PubMed ID: 9378989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective phosphatidic acid-phospholipase C signaling in diabetic cardiomyopathy.
    Tappia PS; Maddaford TG; Hurtado C; Dibrov E; Austria JA; Sahi N; Panagia V; Pierce GN
    Biochem Biophys Res Commun; 2004 Mar; 316(1):280-9. PubMed ID: 15003542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2-mediated activation of phospholipase D in rat heart sarcolemma.
    Liu SY; Tappia PS; Dai J; Williams SA; Panagia V
    J Mol Cell Cardiol; 1998 Jun; 30(6):1203-14. PubMed ID: 9689594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.
    Golfman L; Dixon IM; Takeda N; Lukas A; Dakshinamurti K; Dhalla NS
    Mol Cell Biochem; 1998 Nov; 188(1-2):91-101. PubMed ID: 9823015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin promotes diacylglycerol kinase activation by different mechanisms in rat cerebral cortex synaptosomes.
    Zulian SE; Ilincheta de Boschero MG; Giusto NM
    J Neurosci Res; 2006 Oct; 84(5):1012-9. PubMed ID: 16886188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular defects in sarcolemmal glycerophospholipid subclasses in diabetic cardiomyopathy.
    Vecchini A; Del Rosso F; Binaglia L; Dhalla NS; Panagia V
    J Mol Cell Cardiol; 2000 Jun; 32(6):1061-74. PubMed ID: 10888258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A HPLC-fluorescence detection method for determination of cardiac phospholipase D activity in vitro.
    Kemken D; Mier K; Katus HA; Richardt G; Kurz T
    Anal Biochem; 2000 Nov; 286(2):277-81. PubMed ID: 11067750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed responsiveness of phospholipase C isoenzymes to phosphatidic acid in congestive heart failure.
    Tappia PS; Yu CH; Di Nardo P; Pasricha AK; Dhalla NS; Panagia V
    J Mol Cell Cardiol; 2001 Mar; 33(3):431-40. PubMed ID: 11181012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of myocardial phospholipase D.
    Dai J; Liu SY; Panagia V
    Mol Cell Biochem; 1996; 160-161():83-7. PubMed ID: 8901459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase D and phosphatidate phosphohydrolase activities in rat cerebellum during aging.
    Pasquaré SJ; Salvador GA; Giusto NM
    Lipids; 2004 Jun; 39(6):553-60. PubMed ID: 15554154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase D signaling in ischemic heart.
    Moraru II; Popescu LM; Maulik N; Liu X; Das DK
    Biochim Biophys Acta; 1992 Jun; 1139(1-2):148-54. PubMed ID: 1610913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased activities of phosphatidate phosphohydrolase and phospholipase D in ras and tyrosine kinase (fps) transformed fibroblasts.
    Martin A; Gomez-Muñoz A; Waggoner DW; Stone JC; Brindley DN
    J Biol Chem; 1993 Nov; 268(32):23924-32. PubMed ID: 8226932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-gamma activation in the early streptozotocin diabetic rat lens.
    Lin D; Harris R; Stutzman R; Zampighi GA; Davidson H; Takemoto DJ
    Curr Eye Res; 2007 Jun; 32(6):523-32. PubMed ID: 17612968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.